Video & Transcript DataContr Research : 'FDA'

Page 2 of 8
TX

Texas 2025 - 89th Regular

State Affairs (Part II) Mar 27th, 2025

Senate State Affairs Committee

Transcript Highlights:
  • Under the FDA REMS guidance...
  • The FDA has labeled Kratom as a drug of concern and has stated that there are no FDA-approved uses.
  • I was at the FDA for about 12 years, the last six of which I served as the Deputy Director of FDA.
  • That's an FDA statement. I'm sorry.
  • So I have a statement from the FDA. I've got multiple quotes from the FDA.
Summary: The meeting focused on discussions surrounding several proposed bills, notably SB31, SB33, and SB2880, which address abortion and related healthcare regulations. Prominent advocates for these bills included medical professionals and attorneys who argued for the necessity of stricter regulations to protect unborn children and prevent the indirect funding of abortion-related services. Testimonies featured intense debate, with supporters claiming the bills would enhance accountability and protect both mothers and children, while opponents raised concerns about potential negative impacts on women's health and constitutional rights.
TX

Texas 2025 - 89th Regular

Public Education Apr 8th, 2025 at 08:00 am

House Public Education Committee

Transcript Highlights:
  • I think the state and certainly the FDA are way behind on this.
  • If we don't have faith in the FDA and what has been...
  • You mentioned the conversation about the FDA, because one of the things that I...
  • So your members are saying, FDA, don't change, don't change, don't make us not...
  • If the FDA says it's okay, does that mean you have no liability?
Summary: The committee meeting featured a comprehensive discussion primarily focused on HB1188, which seeks to establish an early connection for families of children diagnosed with intellectual and developmental disabilities to local IDD authorities. Multiple testimonies highlighted the urgent need for such a system, emphasizing how it could transform the experience of families by providing critical information and resources at the moment of diagnosis rather than at a later age. Representative Emanuel passionately presented the bill, underlining its potential to make a significant positive impact in the lives of families across Texas. Additionally, there were discussions regarding other bills related to education and child services, including HB123 and HB2310, with emphasis on the importance of early intervention and support for young children with disabilities.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part II) May 7th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • the FDA.
  • lawyers, saying, "Judge, we don't have enough staff at the FDA to release this for 75 years."
  • Has the FDA, CDC ever published any public guidance on DNA contamination in these shots?
  • approved, like Vioxx, which was ultimately withdrawn despite being FDA approved.
  • I'm an inventor on 25 issued U.S. patents, including an FDA-approved cure for late-stage cancer.
Summary: The committee meeting primarily focused on various significant bills impacting health, family welfare, and vaccinations. Discussion around SB1887 generated notable interest, as it proposed a ten-year prohibition on administering mRNA vaccines, allowing exceptions for cancer treatment and genetic disorders. Senator Sparks, the bill's author, highlighted safety concerns regarding the mRNA technology, stating that further evaluations were necessary. Public testimonies included both support and opposition, with advocates arguing for informed consent and safety, while others expressed concern about restricting scientific advancements in healthcare. Additionally, the conversation addressed HB2216, which aimed at reforming parental rights in child welfare cases, ensuring that parental drug use alone would not warrant automatic termination of rights unless there was a direct, substantial risk to the child. Public testimony for this bill emphasized the need for additional resources to effectively implement its provisions. The committee also discussed HB2809 regarding tracking suicide attempts by children and SB1590 which proposed adopting an electronic process for paternity verification in adoption cases. Overall, the meeting was marked by lively discussions and significant public involvement, indicating the community's vested interest in the legislative outcomes.
TX

Texas 2025 - 89th 2nd C.S.

89th Legislative Session - Second Called Session Aug 27th, 2025 at 10:08 am

Texas House Floor Meeting

Transcript Highlights:
  • winning FDA-approved medicine.
  • It's primarily FDA approved...
  • Ivermectin is safe, affordable, effective, and FDA approved.
  • For instance, Ozempic is also a drug FDA approved for...
  • For treating the parasites, it's FDA approved...
Summary: The meeting included significant discussions on several bills, with a notably vibrant debate around HB25, which seeks to authorize pharmacists to dispense ivermectin without prescription. Supporters highlighted the potential benefits for rural communities by improving access to affordable medications, while opponents raised concerns around safety and the implications of over-the-counter availability. Following extensive discussion, HB25 ultimately passed with a vote of 88 ayes to 51 nays. Additionally, HB192 and HB254 were discussed, both of which passed with strong support, marking a productive session for those advocating for the modernization of public health and infrastructure funding.
TX

Texas 2025 - 89th 2nd C.S.

Senate Session (Part III) Sep 2nd, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • But here's what used to be required by the FDA.
  • FDA.
  • FDA studies.
  • That's right, FDA studies based on 30-year-old information. That's what they're dealing with.
  • Clearly, the FDA should immediately reinstate the procedures that were in place.
Bills: SB2, SB5, SB10, SB9, SB7, SB17, SB4, HB17, HB7, HB7, HB15, HB15, HB27, HB1
Summary: The meeting centered around significant discussions concerning groundwater management, specifically focusing on House Bill 27, which relates to a groundwater study affecting the Neches and Trinity Valleys. Senators debated the necessity of a two-year moratorium on new groundwater permitting, highlighting concerns about potential over-extraction and the ecological impact. Senator Perry expressed urgency for a study to understand the interconnectedness of aquifers, emphasizing the importance of scientific data in guiding legislative decisions, which prompted a detailed examination of current water resources in Texas. The bill was passed with amendments after extensive debate and consideration of various regional impacts.
TX

Texas 2025 - 89th Regular

State Affairs (Part I) Mar 31st, 2025

Senate State Affairs Committee

Transcript Highlights:
  • If it's not authorized by the FDA, it's off the shelf in Texas.
  • I'm also an FDA regulatory consultant.
  • So, I do FDA work every day, so if you have FDA PMTA questions, I'm your person.
  • The FDA list is easily accessible and easy to navigate. It's got 34 products on it.
  • The FDA denied my applications for bottled e-liquid back in 2021.
Summary: The meeting of the Senate Committee on State Affairs featured intense discussions centered around the regulation of tobacco and e-cigarette products, with a particular focus on protecting minors from harmful marketing practices. Senators presented various bills addressing the marketing of these products, which included SB1313, SB1314, and SB1316. Senator Cook laid out SB1313, aimed at prohibiting deceptive marketing techniques that entice minors, alongside testimony from concerned parents advocating for stronger regulations against smoke shops near schools. The committee also examined the App Store Accountability Act, led by Senator Paxson, which aims to ensure age verification for app downloads and hold app stores accountable for protecting minors online. Public testimony played a crucial role in the discussion, with parents and experts weighing in on the necessity of stringent regulations to safeguard youth from exploitation by marketers of addictive products.
TX

Texas 2025 - 89th Regular

Trade, Workforce & Economic Development Apr 23rd, 2025 at 08:04 am

House Trade, Workforce & Economic Development Committee

Transcript Highlights:
  • Please support this bill and support Texas shrimpers and the FDA.
  • And we have no idea, because the FDA is testing less than
  • What standards does the FDA have?
  • Yeah, no, the FDA does have standards.

  • The FDA catches people doing this every quarter, and they're only testing less than one percent.
Summary: The committee meeting focused on several significant bills, with notable discussions revolving around HB2343. This bill, presented by Representative Leo Wilson, aims to enhance transparency in the shrimping industry by requiring restaurants to disclose the origin of shrimp served. The bill was met with mixed reactions, especially from the Texas Restaurant Association, which raised concerns regarding the burdensome requirements for menu updates and potential liability issues if inaccuracies were reported. Meanwhile, the committee passed other bills, including HB4204 aimed at protecting older homeowners from unfair contracts, which received support from AARP Texas and sparked discussions about the implications on consumers' rights. In addition to presentation and testimony on bills, the committee also examined HCR76, which urges the federal government to regulate imports of foreign shrimp, reflecting a proactive stance on protecting local industries from unregulated competition. Overall, the meeting demonstrated a commitment to addressing economic concerns, consumer protection, and the sustainability of local businesses. The chamber was well attended, and many stakeholders provided public testimony for and against the various proposals.
TX

Texas 2025 - 89th Regular

State Affairs (Part I) May 25th, 2025

Senate State Affairs Committee

Transcript Highlights:
  • However, there is some confusion because of changing definitions of pregnancy and the FDA looking at
  • It says an emergency contraceptive approved by the US FDA
  • The handout that we just gave y'all actually has the FDA
  • So that has been the standard; there were the FDA...
  • The new statement that the FDA put out did not specifically address this question, and so that's what
Summary: The committee meeting included significant discussions surrounding several bills, notably HB220, HB3336, and HB4904. HB220, which addresses access to emergency contraception for survivors of sexual assault, sparked intense debate among committee members and witnesses. Various stakeholders testified for and against the bill, emphasizing the importance of immediate access to such services while also raising ethical concerns regarding contraception. Public testimony was robust, showcasing strong opinions on both sides of the legislation, with many advocating for the rights and protections of survivors.
TX

Texas 2025 - 89th Regular

Business and Commerce Mar 18th, 2025

Senate Business & Commerce Committee

Transcript Highlights:
  • These mini-boilers are heavily regulated by the FDA and are also heavily regulated at the state level
  • and autoclaves, the sterilization equipment that I've mentioned, which are already regulated by the FDA
  • You said you have to present a dossier to the FDA before they approve them.
  • However, let's say the FDA had a lack of inspectors or there was something at the federal level where
  • If I might just follow up on Senator Menéndez's question to clarify, if the FDA...
Summary: The committee meeting was marked by a series of discussions regarding several bills aimed at improving local regulations, particularly around food service operations. Members discussed the challenges of regulatory inconsistencies affecting restaurants and the food industry, emphasizing how Senate Bill 1008 could alleviate some financial burdens. Various stakeholders, including representatives from the Texas Restaurant Association, testified in support of this bill, highlighting the need for clearer and more predictable regulations. The discussions included provisions that would cap local permit fees, preventing duplicate charges that hinder small businesses' operations. Notably, there was strong bipartisan support demonstrated as numerous bills were reported favorably with unanimous votes.
TX

Texas 2025 - 89th Regular

Insurance Apr 23rd, 2025 at 08:04 am

House Insurance Committee

Transcript Highlights:
  • span>

    though FDA

  • FDA doesn't require that monitoring to occur in a hospital.
  • We need to ensure that qualified community cancer centers operating under FDA-approved guidelines can
  • data-time="6102"> It contains requirements, such as FACT, as mentioned earlier, due to the lack of FDA
  • cell transplant products because the manufacturing of CAR T-cell therapy products is extensively FDA
Summary: The House Committee on Insurance meeting covered multiple bills focused on healthcare regulations and patient accessibility. Notably, House Bill 3057 was highlighted in testimony from citizens advocating for expanded access to CAR T-cell therapy, which has shown effectiveness for blood cancers. Testimonies were given by affected individuals, emphasizing the need for local treatment options without the burden of travel to distant medical facilities. Similarly, House Bill 4603 was laid out with the intent to align arbitration options and ensure that consumers receive timely resolutions in disputed medical charges. Overall, the committee demonstrated an active engagement with the public and various stakeholders while navigating key issues affecting health insurance and patient care in Texas.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part I) May 21st, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • forms that clearly ...to state that a treatment is not FDA
  • I went through all the FDA-approved drugs quite anxiously
  • I had horrible side effects from the FDA-approved

  • The FDA has viewed that as a drug, taking that approach historically, and that's the reason why Texas
  • ...the FDA and what's allowed out there because this is
Summary: The committee meeting convened to discuss a variety of bills primarily related to healthcare and early childhood education. Notably, the committee reported favorably on several bills including HB721, HB2035, and HB2038, with all receiving unanimous support of 7-0. Senator Perry played a crucial role in moving the bills forward, advocating for their inclusion on the local and uncontested calendars. Furthermore, there was significant discussion surrounding HB3940, which addresses Medicaid eligibility for newborns, emphasizing the necessity for automatic enrollment to avoid gaps in coverage for infants during critical early stages of development. The meeting was characterized by the committee's cohesive efforts to streamline processes and enhance the efficiency of healthcare services for vulnerable populations.
TX

Texas 2025 - 89th 1st C.S.

Agriculture & Livestock Jul 21st, 2025 at 01:07 pm

House Agriculture & Livestock Committee

Transcript Highlights:
  • We've heard that from our FDA colleagues as well.
  • Our FDA colleagues are prepared to respond if the fly were to enter the United States; they could use
  • That has to be approved by the FDA.
  • So there are some outside entities petitioning the FDA to add Ivermectin, but it's going to take time
  • Fortunately, both the EPA and the FDA have emergency use authority.
Summary: The meeting of the committee focused on the urgent issue of the New World Screwworm and its implications for Texas agriculture. Members heard urgent testimonies emphasizing the need for funding and resources to combat the potential spread of this pest, which poses severe threats to livestock and wildlife. Many representatives voiced concerns about the inadequacy of current sterile fly production capacities and the potential economic impact on the state's ranchers and farmers, with estimates suggesting losses could reach billions. Discussions also included coordination efforts among state and federal agencies to prevent the introduction and spread of the pest, with a notable emphasis on the importance of public awareness and rapid response strategies.
TX
Transcript Highlights:
  • span> I think, you know, if we look back in history throughout the FDA
  • Almost 50 years later, in 2018, the FDA finally banned them.
  • Secretary Rollins and presumptive FDA Director Dr.
  • Red Dye No. 3, for example, has been banned in cosmetics for over 30 years, and just last month, the FDA
Summary: The committee convened to discuss SB25, receiving public testimonies from various stakeholders. Significant discussions centered around the implications of the bill, with multiple witnesses voicing their support and concerns. The atmosphere was engaging, with committee members actively questioning the witnesses to clarify their positions and gain deeper insights into the potential impact of the legislation. Chairman's leadership facilitated a structured dialogue that allowed for both support and opposition viewpoints to be expressed.
TX

Texas 2025 - 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025 at 09:04 am

House S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • The FDA does not regulate what a physician...
  • The FDA regulates—Chair recognizes Representative Cunningham as present.
  • The FDA regulates what the manufacturer of that drug can market it to providers for.
  • "> ...one that I was on previously changed and decided, "Well, we're just going to go with what the FDA
  • span marker="289" data-time="1728"> Now, of course, the FDA
Summary: The committee meeting engaged in comprehensive discussions surrounding various health-focused bills aimed at improving community services and mental health care access. Notably, House Bill 475 was refiled by Representative Johnson, highlighting the deficiencies in Texas Medicaid regarding community-based care for youth at risk for criminal behavior. The committee examined the merits of the bill, emphasizing the need for evidence-based intervention programs. Meanwhile, House Bill 2060 received attention for its focus on ensuring automatic Medicaid coverage for infants, addressing gaps in access highlighted by a report indicating a significant number of newborns missed enrollment at birth. Members expressed strong support for this initiative, delineating the critical nature of health coverage for Texas’ youngest citizens.
TX
Transcript Highlights:
  • This standard is issued by the FDA and followed by all blood banks.
  • Additionally, while the FDA guidelines for blood donation

  • So, some of this was mentioned earlier, but the FDA

  • Currently, only 39 of Texas's hospitals are registered with the FDA to collect blood.
  • And absolutely, we have no concerns regarding the hospitals that are currently licensed by the FDA to
Summary: The meeting of the Senate Committee on Health and Human Services focused primarily on several key bills aimed at improving health care regulations and patient rights. Notably, Senator Hall introduced SB125, aiming to allow for direct and autologous blood donations, which sparked passionate debates among committee members and invited witnesses. Concerns were raised regarding the bill's implications for patient safety and the feasibility of the proposed 72-hour notice period for hospitals. Testimonies highlighted personal experiences, including that of the Lehrer family, advocating for the bill based on their children's health needs and the challenges faced due to current regulations. Conversely, several representatives from blood centers expressed opposition, cautioning that the bill could burden the blood donation system and adversely impact the quality of care for patients with special needs. Additionally, SB315 was present to address genetic privacy issues, aiming to grant Texans property rights over their DNA and genetic information. This bill also brought forth discussions about the ethical implications of genetic testing and data privacy in light of technological advancements. As the meeting progressed, representatives underscored the importance of balancing legislative intentions with practical outcomes, initiating further discussions on amendments and committee substitutes that would refine the proposed laws.
TX
Transcript Highlights:
  • This continuing theme of the FDA, through Republican and Democratic administrations, is just failing
  • The FDA has a list of 16 approved active ingredients for use in sunscreens.
  • ...approval by the FDA, again using the model of the Texas
  • I think this is about as low as we are going to get in recognizing what the FDA has done to us.
  • to just being able to go around them, because I have no confidence that anything coming out of the FDA
Summary: The meeting involved in-depth discussions focused primarily on several significant bills aimed at reforming healthcare, improving consumer protection, and enhancing community-based care. Key highlights included House Bill 1919 and House Bill 1763, which address the roles and regulation of pharmacy benefit managers (PBMs) in Texas. Lawmakers emphasized the need for these bills to create a fairer landscape for independent pharmacies while ensuring patient access to necessary medications. Public testimonies reflected both support for the reforms and concerns regarding their potential implications. Another major topic was Senate Bill 513, which proposes the development of a pilot program for community-based care in rural West Texas, aiming to improve child welfare services in regions facing unique challenges.
TX

Texas 2025 - 89th Regular

Health and Human Services May 20th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • Actually, the FDA changed their requirement this week; they are going to look at the COVID vaccine a
  • And so I think the FDA is properly backstepping and

  • So I'm looking at the stuff that came out from the FDA. It looks like today.
  • The FDA is making changes to the requirements as they move forward.
  • ...care facility that meets FDA regulations.
Summary: The meeting of the Senate Committee on Health and Human Services discussed multiple bills focused on diverse health issues including maternal care, organ transplant eligibility, and child welfare regulations. Notably, HB215, presented by Senator Perry, received attention for its provisions on requiring itemized bills from healthcare providers to enhance transparency. The bill garnered support from various witnesses who emphasized the importance of clearer billing processes for patients. Another significant discussion point was HB4076, which aimed to prevent discrimination against individuals seeking organ transplants based on vaccination status. This bill sparked public testimony highlighting the ethical implications of such mandates on vulnerable patients, especially children. Overall, the committee's deliberations emphasized a commitment to improving health care transparency and patient rights in Texas.
TX

Texas 2025 - 89th Regular

Public Health May 5th, 2025 at 08:05 am

House Public Health Committee

Transcript Highlights:
  • the Federal Vaccine Adverse Events Reporting System has been in use for over two decades, the CDC and FDA
  • However, the FDA – shockingly – has not approved new UV blocking filters since 1996 due to their lengthy
  • 7488"> completed phase one of the clinical trial but have not yet been approved for general use by the FDA
  • The FDA has a list of 16 approved active ingredients, while the European Union has 48 allowed UV filters
  • The FDA approval process is cumbersome, in part because it classifies sunscreens typically as drugs instead
Summary: The committee meeting included a range of discussions on various bills, notably focusing on mental health and public safety. Senate Bill 528, aiming to improve accountability in mental health treatment for individuals found incompetent to stand trial, received significant support from public testimonies. Witnesses emphasized the need for better coordination and transparency in service provisions, shedding light on the backlog of individuals requiring forensic mental health services in Texas. Additionally, Senate Bill 1388 was discussed as a means to enhance the Thriving Texas Families Program which supports women and families facing unplanned pregnancies, garnering both endorsements and concerns about its implementation.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 28th, 2025 at 10:05 am

Texas House Floor Meeting

Transcript Highlights:
  • when the FDA took over the regulation of vapes here in this country.
  • If they go and submit their product to the FDA today, they submit their application to the FDA.
  • If you are with that product able to get FDA approval.
  • More jobs ensure that it's safe here at those FDA facilities.
  • FDA 2016?
Bills: SB15, SB646, SB800, SB790, SB748, SB571, SB1957, SB1923, SB1896, SB1760, SB1335, SB2368, SB2477, SB2587, SB2986, SB2965, SB1563, SB1467, SB1164, SB1137, SB614, SB705, SB918, SB955, SB869, SB850, SB863, SB1055, SB2206, SB457, SB2337, SB1610, SB1362, SB926, SB1494, SB251, SB456, SB500, SB1307, SB2615, SB2995, SB2321, SB2972, SB973, SB865, SB506, SB1522, SB1558, SB510, SB667, SB763, SB2073, SB1858, SB1660, SB2900, SB1433, SB1540, SB1964, SB1300, SB1644, SB2217, SB2373, SB2431, SB1758, SB974, SB2480, SB3039, SB3047, SB2781, SB826, SB766, SB527, SB1946, SB2885, SB1243, SB2610, SB857, SB2501, SB66, SB268, SB331, SB1302, SB519, SB2807, SB13, SB7, SB1718, SB1567, SB1233, SB413, SB2177, SB30, SB2024, SJR1, SCR27, SB2018, SB1580, SB2121, SB1049, SB1266, SB1400, SB1596, SB2753, SB2221, SB1719, SCR9, SB204, SB437, SB568, SB612, SB672, SB710, SB823, SB876, SB904, SB905, SB968, SB1084, SB1207, SB1230, SB1313, SB1504, SB1790, SB2232, SB2366, SB2367, SB2398, SB2515, SB2520, SB2589, SB2786, SB2790, SB3048, SB3050, SB3052, SB3053, SB3056, SB3029, SCR3, SCR18, SCR30, HCR146, HCR148, HCR149, HCR153, HCR155, HCR157, HB5560, HB762, HB1584, HB107, HB114, HB138, HB4386, HB2495, HB581, HB3348, HB5323, HB4341, HB6, HB2712, HB171, HB3153, HB143, HB2688, HB3464, HB449, HB3486, HB4263, HB2, HB1522, HB24, HB1237, HB2637, HB3126, HB3233, HB4310, HB3487, HCR9, HB5331, HB1397, HB163, HB3250, HB3071, HB3463, HB5033, HB35, HB3824, HB216, HB4226, HB3512, HB18, HB5154, HB103, HB851, HB647, HB4520, HB3016, HB2313, HB2818, HB2851, HB4486, HB4264, HB1500, HB5081, HB2974, HB2080, HB4384, HB5659, HB493, HB4903, HB2516, HB4488, HB4530, HB3689, HB145, HB43, HB5247, HB2221, HB5671, HB700, HB3711, HB120, SB17, SB1637, SB1833, SB2155, SB21, SB2778, SB379
Summary: The meeting featured a comprehensive discussion involving several bills primarily focused on education, mental health, and public safety. Notable was the passage of SB204, which establishes a parental rights handbook that consolidates various rights pertaining to education and training for school district trustees. The bill was passed unanimously, highlighting strong bipartisan support for parental engagement in education. Additionally, the committee discussed SB2277, which allocates funding to assist local law enforcement with violent crime rates, indicative of a heightened concern over public safety. Amendments and testimonies highlighted the various stakeholders' views, emphasizing the importance of community engagement in legislative measures.

Research Filters

States
Terms / Sessions
Date Range
Chamber Records
Meetings / Events / Calendars